Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
United European Gastroenterology Journal · 2024
DOI: 10.1002/ueg2.12671 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Tommaso Lorenzo Parigi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Transplantation and Infectious Disease, Università Vita-Salute San Raffaele, Milan, Italy. Hauptthemen laut MEDLINE: Intestinal Mucosa, Randomized Controlled Trials as Topic, Wound Healing, Colitis, Ulcerative. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Mucosal healing (MH) is an established treatment goal in inflammatory bowel disease (IBD). However, various definitions of MH exist. We aimed to identify how MH is defined in randomized controlled trials (RCTs) in ulcerative colitis (UC) and Crohn's disease (CD).
Methods
We searched MEDLINE, EMBASE, and the Cochrane library from inception to December 2023 for phase 2 and 3 RCTs of advanced therapies in IBD.
Results
One hundred forty‐four studies were included, 72 in UC and 72 in CD, published between 1997 and 2023. In UC, 64% (46/72) RCTs reported MH as an endpoint. 12 definitions of MH were found, from endoscopic assessment alone (35/46; 76%) to the more recent combination of histology and endoscopy (10/46; 22%). 96% (44/46) of studies used the Mayo Endoscopic Subscore. In CD, reporting of MH lagged behind UC, with only 12% (9/72) of trials specifically defining MH as an endpoint, 7 as “absence of ulceration,” 2 as Simplified Endoscopic Score for CD score ≤2 or 0. Histological assessment was performed in 3 RCTs of CD. Centralized reading of endoscopy was used in 48% (35/72) of RCTs of UC and 22% (16/72) of CD. Only 1 RCT included transmural healing as an endpoint.
Conclusions
A standard definition of MH in IBD is lacking. Definitions have evolved particularly in UC, which now includes the addition of histological evaluation. Transmural healing holds promise as a future target in CD. We support a greater standardization of definitions as we expect endpoints to become increasingly stringent and multimodal with computers automating the assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Immunology, Transplantation and Infectious Disease, Università Vita-Salute San Raffaele, Milan, Italy.
- Department of Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele, Milan, Italy.
- Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
- IBD Center, IRCCS Humanitas Research Hospital, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Gastroenterology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago, Spain.
ORCID-Profile: Manuel Barreiro de Acosta, Shomron Ben-Horin, Taku Kobayashi, Fernando Magro, Christian Selinger, Vipul Jairath, Laurent Peyrin-Biroulet
Zitieren
APA
Parigi, T. L., Solitano, V., Armuzzi, A., Barreiro de Acosta, M., Begun, J., Ben-Horin, S., Biedermann, L., Colombel, J. F., Dignass, A., Fumery, M., Ghosh, S., Kobayashi, T., Louis, E., Magro, F., Panaccione, R., Rausch, A., Reinisch, W., Selinger, C., Jairath, V., …, & Peyrin-Biroulet, L. (2024). Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12671
Vancouver
Parigi TL, Solitano V, Armuzzi A, Barreiro de Acosta M, Begun J, Ben-Horin S, et al. Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12671
BibTeX
@article{Parigi2024,
author = {Parigi, Tommaso Lorenzo and Solitano, Virginia and Armuzzi, Alessandro and Barreiro de Acosta, Manuel and Begun, Jake and Ben-Horin, Shomron and Biedermann, Luc and Colombel, Jean-Frederic and Dignass, Axel and Fumery, Mathurin and Ghosh, Subrata and Kobayashi, Taku and Louis, Edouard and Magro, Fernando and Panaccione, Remo and Rausch, Astrid and Reinisch, Walter and Selinger, Christian and Jairath, Vipul and Danese, Silvio and Peyrin-Biroulet, Laurent},
title = {Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective},
journal = {United European Gastroenterology Journal},
year = {2024},
doi = {10.1002/ueg2.12671}
}
EUVIMED